Marathon is the fourth-largest U.S.-based fully integrated international energy company engaged in exploration and production; integrated gas; and refining, marketing and transportation operations. The company has principal exploration and production activities in the United States, the United Kingdom, Angola, Canada, Equatorial Guinea, Gabon, Ireland, Libya, Norway and Russia. Marathon also is developing integrated gas projects that are linking stranded natural gas resources with key demand areas where domestic production is declining and demand is growing, particularly in North America. Marathon is the fifth largest refiner in the U.S. The Corporation's retail marketing system comprises approximately 5,500 locations in 17 states.
Bioko Island Malaria Control Project
Malaria is endemic in Equatorial Guinea and is the number one killer in sub-Saharan Africa. The high prevalence of malaria on Bioko Island contributes significantly to an estimated mortality rate of 17 percent in children under five years of age. This is more than 20 times higher than the mortality rate in the United States. Even when not fatal, malaria compromises the health and productivity of many people, and significantly impacts the financial well-being of families, especially those least able to afford medication.
Recognizing the threat posed by malaria, Marathon and its business partners teamed up with the Government of Equatorial Guinea to implement the Bioko Island Malaria Control Project and fight the disease on the island. The implementation team is comprised of leading health specialists from Medical Care Development International (MCDI), One World Development Group, the Medical Research Council of South Africa and Yale University Medical School. Implementation is being led by MCDI and began in October 2003. The program employs three main interventions: vector control, improved case management, and surveillance and evaluation.